BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11263778)

  • 1. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome.
    Nakken B; Jonsson R; Bolstad AI
    Arthritis Rheum; 2001 Mar; 44(3):638-46. PubMed ID: 11263778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.
    Miyagawa S; Shinohara K; Nakajima M; Kidoguchi K; Fujita T; Fukumoto T; Yoshioka A; Dohi K; Shirai T
    Arthritis Rheum; 1998 May; 41(5):927-34. PubMed ID: 9588746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjögren's syndrome.
    Imanishi T; Morinobu A; Hayashi N; Kanagawa S; Koshiba M; Kondo S; Kumagai S
    Clin Exp Rheumatol; 2005; 23(4):521-4. PubMed ID: 16095123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart.
    Chan EK; Di Donato F; Hamel JC; Tseng CE; Buyon JP
    J Exp Med; 1995 Oct; 182(4):983-92. PubMed ID: 7561701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies against recombinant Ro 60 Kd, Ro 52 and La 48 Kd proteins in primary Sjogren's Syndrome. Utility of analytic methods combination to detect antibodies anti Ro and La].
    Aguilera S; González MJ; Pérez P; Castillo D; Gatica H
    Rev Med Chil; 2002 Aug; 130(8):841-9. PubMed ID: 12360791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjögren's syndrome.
    Dörner T; Feist E; Held C; Conrad K; Burmester GR; Hiepe F
    Hepatology; 1996 Dec; 24(6):1404-7. PubMed ID: 8938170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
    Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
    Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
    Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
    Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays.
    McCauliffe DP; Wang L; Satoh M; Reeves WH; Small D
    J Rheumatol; 1997 May; 24(5):860-6. PubMed ID: 9150073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
    Ricchiuti V; Isenberg D; Muller S
    J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjögren's syndrome.
    Elagib KE; Tengnér P; Levi M; Jonsson R; Thompson KM; Natvig JB; Wahren-Herlenius M
    Arthritis Rheum; 1999 Nov; 42(11):2471-81. PubMed ID: 10555043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren's syndrome.
    Cho CS; Park SH; Min JK; Lee SH; Kim HY
    Korean J Intern Med; 1997 Jun; 12(2):176-81. PubMed ID: 9439152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls.
    Garberg H; Jonsson R; Brokstad KA
    Scand J Rheumatol; 2005; 34(1):49-55. PubMed ID: 15903026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoepitopes of the 52-kd SS-A/Ro molecule.
    Kato T; Sasakawa H; Suzuki S; Shirako M; Tashiro F; Nishioka K; Yamamoto K
    Arthritis Rheum; 1995 Jul; 38(7):990-8. PubMed ID: 7541994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome.
    Arnett FC; Hamilton RG; Reveille JD; Bias WB; Harley JB; Reichlin M
    Arthritis Rheum; 1989 Apr; 32(4):413-9. PubMed ID: 2706027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.
    Harley JB; Alexander EL; Bias WB; Fox OF; Provost TT; Reichlin M; Yamagata H; Arnett FC
    Arthritis Rheum; 1986 Feb; 29(2):196-206. PubMed ID: 3485431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?
    Scofield AN; Kurien BT; Gordon TP; Scofield RH
    Lupus; 2001; 10(8):547-53. PubMed ID: 11530996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.
    Billaut-Mulot O; Cocude C; Kolesnitchenko V; Truong MJ; Chan EK; Hachula E; de la Tribonnière X; Capron A; Bahr GM
    J Clin Invest; 2001 Sep; 108(6):861-9. PubMed ID: 11560955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.